Atai Life Sciences Net Income 2020-2025 | ATAI

Atai Life Sciences net income from 2020 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Atai Life Sciences Annual Net Income
(Millions of US $)
2024 $-149
2023 $-40
2022 $-152
2021 $-168
2020 $-170
2019 $-14
Atai Life Sciences Quarterly Net Income
(Millions of US $)
2025-03-31 $-26
2024-12-31 $-39
2024-09-30 $-26
2024-06-30 $-57
2024-03-31 $-27
2023-12-31 $-18
2023-09-30 $44
2023-06-30 $-33
2023-03-31 $-33
2022-12-31 $-45
2022-09-30 $-34
2022-06-30 $-37
2022-03-31 $-37
2021-12-31 $-89
2021-09-30 $-31
2021-06-30 $-48
2021-03-31 $1
2020-12-31 $-87
2020-09-30 $-83
2020-06-30 $-16
2020-03-31 $16
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.423B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $20.083B 19.79
Encompass Health (EHC) United States $12.188B 25.84
DaVita (DVA) United States $10.642B 14.96
Chemed (CHE) United States $8.153B 25.62
Elanco Animal Health (ELAN) United States $6.710B 14.37
Option Care Health (OPCH) United States $5.282B 23.55
RadNet (RDNT) United States $4.185B 265.62
Amedisys (AMED) United States $3.205B 21.56
Addus HomeCare (ADUS) United States $2.098B 23.04
LifeStance Health (LFST) United States $1.975B 0.00
Astrana Health (ASTH) United States $1.497B 37.08
U.S Physical Therapy (USPH) United States $1.201B 31.00
Pennant (PNTG) United States $1.003B 36.82
Aveanna Healthcare Holdings (AVAH) United States $0.970B 55.22
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.038B 0.00
Ontrak (OTRK) United States $0.004B 0.00
Psychemedics (PMD) United States $0.000B 0.00